5-(4-tert-butylphenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 500mg

3-Chloro-5-nitrobenzoic acid, 95.0%, 100g

2,3-Difluoro-6-methoxyaniline, 5g

10-(3-CHLOROPROPYL)-2-(TRIFLUOROMETHYL)-10H-PHENOTHIAZINE, 95%, 1g

2-(2-Bromoethyl)-1,3-dioxolane>90.0%(GC)100g

Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate, 95.0%, 100mg

2-(diethylamino)ethyl 3-amino-4-propoxybenzoate hydrochloride, 98.0%, 250mg

monoclonal de ratón anti-queratina K19, Ks19.2 (Z105.6), 0,2 ml

1,3,5-Tris(4-(tert-butyl)-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazinane-2,4,6-trione, 97%, 500g

1H-Pyrrolo[3,2-b]pyridin-5-amine hydrochloride, 95.0%, 5g

3-Methylquinolin-8-amine, 97%, 100mg

((2R,3R,4R,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate, 98%, 100mg

(S)-4-(Pyrrolidin-2-yl)pyridine, 10g